Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

An L-shaped association between serum vitamin D levels and mortality was identified.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Serum 25(OH)D levels and mortality risk among middle-aged and elderly populations in the U.S.: A prospective cohort study

Source: Article title.

A total of 22,130 participants aged 40 to 70 years were included.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum 25(OH)D levels and mortality risk among middle-aged and elderly populations in the U.S.: A prospective cohort study

Cohort study · PLOS One · 2025

Original publication title

Serum 25(OH)D levels and mortality risk among middle-aged and elderly populations in the U.S.: A prospective cohort study

Yaowen Hu; Faliang Gao; Yuan Yang; Wei Yang; Huibo He; Jie Zhou; Yujie Zhao; Xi Chen; Wenyan Zhao; Xiaopeng He

© 2025 Hu et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study found that higher serum 25-hydroxyvitamin D concentrations are linked to lower all-cause, cardiovascular, and cancer mortality. The relationship is nonlinear: increases in concentration reduce death risk below a certain threshold, but above it, the association weakens. Further research is needed to understand causal mechanisms.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To investigate the prevalence of vitamin D deficiency and its relationship with all-cause and cause-specific mortality among middle-aged and elderly populations in the U.S.

Source: Objective

Abstract: What methods does the paper describe?

Data were sourced from the National Health and Nutrition Examination Survey (NHANES) 2001 to 2018. A total of 22,130 participants aged 40 to 70 years were included. Serum 25-hydroxy vitamin D [25(OH)D] concentrations were measured and categorized. The primary outcome was all-cause mortality, and secondary outcomes were cardiovascular disease (CVD) and cancer mortality. Multivariable-adjusted models and various statistical analyses were employed.

Source: Methods

Abstract: Results

The prevalence of vitamin D deficiency (≤50.00 nmol/L) was 33.59%, and insufficiency (≤75.00 nmol/L) was 71.74%. For all-cause mortality, the multivariate adjusted hazard ratios (HRs) across different 25(OH)D levels (< 25.00, 25.00 to 49.99, 50.00 to 74.99, and ≥ 75.00 nmol/L) were 1.00, 0.78 (0.65, 0.93) p = 0.0069, 0.59 (0.49,0.72) p < 0.0001, and 0.54 (0.44, 0.66) p < 0.0001 respectively. Similar patterns were observed for CVD mortality. There was no significant difference in cancer mortality between the moderately deficient and severely deficient groups, but lower mortality was found in the insufficient and sufficient groups compared to the severely deficient group.

An L-shaped association between serum vitamin D levels and mortality was identified. Subgroup analyses were consistent with the main findings.

Source: Results

Abstract: Conclusion

This study found that higher serum 25-hydroxyvitamin D concentrations are linked to lower all-cause, cardiovascular, and cancer mortality. The relationship is nonlinear: increases in concentration reduce death risk below a certain threshold, but above it, the association weakens. Further research is needed to understand causal mechanisms.

Source: Conclusion
Authors’ abstract

Objective

To investigate the prevalence of vitamin D deficiency and its relationship with all-cause and cause-specific mortality among middle-aged and elderly populations in the U.S.

Methods

Data were sourced from the National Health and Nutrition Examination Survey (NHANES) 2001 to 2018. A total of 22,130 participants aged 40 to 70 years were included. Serum 25-hydroxy vitamin D [25(OH)D] concentrations were measured and categorized. The primary outcome was all-cause mortality, and secondary outcomes were cardiovascular disease (CVD) and cancer mortality. Multivariable-adjusted models and various statistical analyses were employed.

Results

The prevalence of vitamin D deficiency (≤50.00 nmol/L) was 33.59%, and insufficiency (≤75.00 nmol/L) was 71.74%. For all-cause mortality, the multivariate adjusted hazard ratios (HRs) across different 25(OH)D levels (< 25.00, 25.00 to 49.99, 50.00 to 74.99, and ≥ 75.00 nmol/L) were 1.00, 0.78 (0.65, 0.93) p = 0.0069, 0.59 (0.49,0.72) p < 0.0001, and 0.54 (0.44, 0.66) p < 0.0001 respectively. Similar patterns were observed for CVD mortality. There was no significant difference in cancer mortality between the moderately deficient and severely deficient groups, but lower mortality was found in the insufficient and sufficient groups compared to the severely deficient group.

An L-shaped association between serum vitamin D levels and mortality was identified. Subgroup analyses were consistent with the main findings.

Conclusion

This study found that higher serum 25-hydroxyvitamin D concentrations are linked to lower all-cause, cardiovascular, and cancer mortality. The relationship is nonlinear: increases in concentration reduce death risk below a certain threshold, but above it, the association weakens. Further research is needed to understand causal mechanisms.

Publication and source details

Original title: Serum 25(OH)D levels and mortality risk among middle-aged and elderly populations in the U.S.: A prospective cohort study

Yaowen Hu; Faliang Gao; Yuan Yang; Wei Yang; Huibo He; Jie Zhou; Yujie Zhao; Xi Chen; Wenyan Zhao; Xiaopeng He

PLOS One · 2025

* E-mail: hexiaopeng411@163.com (XPH); zhaowenyan@hmc.edu.cn (WYZ); vipxichen@126.com (XC)

Competing Interests: The authors have declared that no competing interests exist.

☯ These authors contributed equally to this work.

© 2025 Hu et al2025Hu et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://dx.doi.org/10.13039/501100017599Science and Technology Program of Zhejiang Province 2024KY652 Gao Faliang http://dx.doi.org/10.13039/501100012175Zhejiang Traditional Chinese Medicine Administration 2025ZL188 Gao Faliang This study were financially supported by Zhejiang Province Health Science and Technology Project (grant no. 2024KY652) and Zhejiang Province Traditional Chinese Medicine Science and Technology Project (grant no. 2025ZL188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:22:38.218758+00:00

DOI: 10.1371/journal.pone.0328907 · PMC12289007